Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01278446 · ClinicalTrials.gov registry record · NA
Extensively Hydrolyzed Formula: Hypoallergenicity
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
NCT01278446 is a NA study that has completed, run by Société des Produits Nestlé (SPN).
The verdict
NCT01278446, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The primary objective of this clinical trial is to determine whether a new extensively hydrolyzed infant formula is hypoallergenic.
Interventions
- OTHER Extensively hydrolyzed, whey protein infant formula
- OTHER Extensively hydrolyzed, casein protein infant formula
Trial Details
| Field | Value |
|---|---|
| Start Date | 2011-02 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01278446
The ClinicalTrials.gov registry entry for NCT01278446 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Extensively hydrolyzed, whey protein infant formula is the first listed.
NCT01278446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01278446 about?
NCT01278446 is a clinical study titled "Extensively Hydrolyzed Formula: Hypoallergenicity". The primary objective of this clinical trial is to determine whether a new extensively hydrolyzed infant formula is hypoallergenic.
What is the current status of trial NCT01278446?
This trial is currently completed. It is a NA study. The study started on 2011-02. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01278446?
The interventions under investigation include: Extensively hydrolyzed, whey protein infant formula (OTHER), Extensively hydrolyzed, casein protein infant formula (OTHER).
Who is sponsoring clinical trial NCT01278446?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.